[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Advisory Board
Aims & Scope
Journal News
Articles archive::
All Issues
Current Issue
Articles in press
For Authors::
Submission Instruction
For Reviewers::
Reviewers Section
Subscription::
Subscription Form
News& Events::
Journal News
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
Top 10 contents
Inform others
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 20, Issue 1 (Spring 2023) ::
Sci J Iran Blood Transfus Organ 2023, 20(1): 66-80 Back to browse issues page
COVID-19 and Transfusion
N. Kazemi Babaahmadi , M. Kheirandish
Keywords: COVID-19, Transfusion, Plasma, SARS-COV-2
Full-Text [PDF 874 kb]   (548 Downloads)     |   Abstract (HTML)  (729 Views)
Type of Study: Review Article | Subject: Infectious disease
Published: 2023/04/4
Full-Text:   (479 Views)
    References:
  1. Chang L, Yan Y, Wang L. Coronavirus Disease 2019: Coronaviruses and Blood Safety. Transfus Med Rev 2020; 34(2): 75-80.
  2. Whitworth J. COVID-19: a fast evolving pandemic. Trans R Soc Trop Med Hyg 2020; 114(4): 241-8.
  3. Chakraborty I, Maity P. COVID-19 outbreak: Migration, effects on society, global environment and prevention. Sci Total Environ 2020; 728: 138882. 
  4. Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview. Clin Imaging 2020; 66: 35-41. 
  5. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020; 45(8): 100618.
  6. Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, et al. An overview of COVID-19. J Zhejiang Univ Sci B 2020; 21(5): 343-60.
  7. Jamwal S, Gautam A, Elsworth J, Kumar M, Chawla R, Kumar P. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic. Life Sci 2020; 257: 118105.
  8. Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol 2021; 93(1): 250-6.
  9. Kazemibabaahmadi N, Kheirandish M. SARS-COV-2 Virus; Immune Responses and The Immunopathogenesis. Sci J Iran Blood Transfus Organ 2022; 19(1): 75-97. [Article in Farsi]
  10. Noroozi-Aghideh   A,  Kheirandish   M. Human   cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review. World J Stem Cells 2019; 11(2): 73-83. 
  11. Golchin N, Kheirandish M, Sharifi Z, Samiee S, Kokhaei P, Pourpak Z. Quantification of viral genome in cord blood donors by real time PCR to investigate human herpesvirus type 8 active infection. Transfus Apher Sci 2015; 53(3): 378-80. 
  12. Abedi E, Kheirandish M, Sharifi Z, Samiee S, Kokhaei P, Pourpak Z, et al. Quantitative polymerase chain reaction for detection of human herpesvirus-7 infection in umbilical cord blood donors. Transpl Infect Dis 2015; 17(1): 21-4. 
  13. Abedi E, Kheirandish M, Sharifi Z, Samiee S, Kokhaei P, Pourpak Z, Ashraf MJ. Quantification of Active and Latent Form of Human Cytomegalovirus Infection in Umbilical Cord Blood Donors by Real-Time PCR. Int J Organ Transplant Med 2017; 8(3): 140-5. 
  14. Jahangiryan A, Kheirandish M, Samiee Sh, Sharifi Z, Alaei M. Determination of Epstein-Barr virus (EBV) incidence in umbilical cord blood (UCB) and assessment of virus DNA via Real-time PCR. Ann Cancer Res Ther 2021; 29(1): 114-20.
  15. Baron DM, Franchini M, Goobie SM, Javidroozi M, Klein AA, Lasocki S, et al. Patient blood management during the COVID–19 pandemic: a narrative review. Anaesthesia 2020; 75(8): 1105-13.
  16. Kandasamy D, Shastry S, Chenna D, Mohan G. COVID-19 pandemic and blood transfusion services: The impact, response and preparedness experience of a tertiary care blood center in southern Karnataka, India. Hematol Transfus Cell Ther 2022; 44(1): 17-25.
  17. Chiem C, Alghamdi K, Nguyen T, Han JH, Huo H, Jackson D. The impact of COVID-19 on blood transfusion services: a systematic review and meta-analysis. Transfus Med Hemother 2022; 49(2): 107-18.
  18. Shan H, Zhang P. Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing. Transfusion 2004; 44(4): 467-9.
  19. Haw J, Holloway K, Masser BM, Merz EM, Thorpe R. Blood donation and the global COVID-19 pandemic: areas for social science research. Vox Sang 2021; 116(4): 363-5.
  20. Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 2020; 21: 100331.
  21. Cai X, Ren M, Chen F, Li L, Lei H, Wang X. Blood transfusion during the COVID-19 outbreak. Blood Transfus 2020; 18(2): 79-82.
  22. Veseli B, Sandner S, Studte S, Clement M. The impact of COVID-19 on blood donations. PLoS One 2022; 17(3): e0265171.
  23. Gkirtsou C, Konstantinidis T, Cassimos D, Konstantinidou EI, Kontekaki EG, Rekari V, et al. Views and Attitudes of Blood Donors toward Blood Donation during the COVID-19 Pandemic in Thrace Region,  Greece.  Int  J  Environ  Res  Public    Health 2022; 19(9): 4963.
  24. Sahu KK, Raturi M, Siddiqui AD, Cerny J. "Because Every Drop Counts": Blood donation during the COVID-19 Pandemic. Transfus Clin Biol 2020; 27(3): 105-8.
  25. Ngo A, Masel D, Cahill C, Blumberg N, Refaai MA. Blood banking and transfusion medicine challenges during the COVID-19 pandemic. Clin Lab Med 2020; 40(4): 587-601.
  26. Pagano MB, Hess JR, Tsang HC, Staley E, Gernsheimer T, Sen N, et al. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State. Transfusion 2020; 60(5): 908-11.
  27. Warner MA, Patel PA, Hensley NB, Mazzeffi M. COVID-19-Related Blood Shortages and Cardiac Surgery: Do We Have Too Many Eggs in One Basket? J Cardiothorac Vasc Anesth 2022; 36(7): 1823-6.
  28. Riley W, Love K, McCullough J. Public policy impact of the COVID-19 pandemic on blood supply in the United States. Am J Public Health 2021; 111(5): 860-6.
  29. Worldwide, AABBs Resources for: FDAs Updated Information for Blood Establishments Regarding The novel Coronavirus (COVID-19). Outbreak. March, 2020.
  30. Kasanga M, Mudenda S, Gondwe T, Chileshe M, Solochi B, Wu J. Impact of COVID-19 on blood donation and transfusion services at Lusaka provincial blood transfusion centre, Zambia. Pan Afr Med J 2020; 35(Suppl 2): 74.
  31. Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, et al. Impact of the Coronavirus (COVID-19) pandemic on surgical practice-Part 2 (surgical prioritisation). Int J Surg 2020; 79: 233-48.
  32. Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 2020; 7(10): e756-e64. 
  33. Leung JN, Lee CK. Impact of the COVID-19--a regional blood centre's perspective. ISBT Science Series 2020; 15(4): 362-4.
  34. Raturi M, Kusum A. The blood supply management amid the COVID-19 outbreak. Transfus Clin Biol 2020; 27(3): 147-51.
  35. Tripathi PP, Kumawat V, Patidar GK. Donor’s Perspectives on Blood Donation During Covid-19 Pandemic. Indian J Hematol Blood Transfus 2022; 38(3): 536-45. 
  36. Wang, Y., et al., Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang 2020; 115(6): 502-6.
  37. Gehrie E, Tormey CA, Sanford KW. Transfusion service response to the COVID-19 pandemic. Am J Clin Pathol 2020; 154(3): 280-5.
  38. Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM. Emerging infectious diseases and blood safety: modeling the transfusion-transmission risk. Transfus Med Rev 2017; 31(3): 154-64.
  39. Kiely P, Hoad VC, Seed CR, Gosbell IB. Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency. Vox Sang 2021; 116(2): 155-66.
  40. Cappy P, Candotti D, Sauvage V, Lucas Q, Boizeau L, Gomez J, et al. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood 2020; 136(16): 1888-91.
  41. Corman VM, Rabenau HF, Adams O, Oberle D, Funk MB, Keller-Stanislawski B, et al. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion 2020; 60(6): 1119-22.
  42. Leblanc JF, Germain M, Delage G, OʼBrien S, Drews SJ, Lewin A. Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: a literature review. Transfusion 2020; 60(12): 3046-54.
  43. Langhi DM, de Souza RC, Barros M, De Santis GC, Kashima SH, Bordin JO. SARS-COV-2: is it a risk for blood transfusion? Hematol Transfus Cell Ther 2022; 44: 100-3.
  44. Cho HJ, Koo JW, Roh SK, Kim YK, Suh JS, Moon JH, et al. COVID-19 transmission and blood transfusion: A case report. J Infect Public Health 2020; 13(11): 1678-9.
  45. COVID A. weekly hospital transfusion services survey.week 21 snapshot; 2020.
  46. Hashemieh M. Blood Safety in SARS-CoV-2 Infection. Arch Pediatr Infect Dis 2020; 8(3): e104525.
  47. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
  48. Bouhou S, Lahjouji K, Benajiba M, Masrar A. Impact of the COVID-19 pandemic on blood transfusion systems: International review and the Moroccan blood transfusion system experience. Int J Blood Transfus Immunohematol 2021; 11: 100065Z02SB2021.
  49. Han J, Chen L, Duan SM, Yang QX, Yang M, Gao C, et al. Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts. Biomed Environ Sci 2005; 18(3): 176-80.
  50. Lamarre A, Talbot PJ. Effect of pH and temperature on the infectivity of human coronavirus 229E. Can J Microbiol 1989; 35(10): 972-4.
  51. Rebulla P. The long and winding road to pathogen reduction of platelets, red blood cells and whole blood. Br J Haematol 2019; 186(5): 655-67.
  52. Seltsam A, Müller TH. Update on the use of pathogen-reduced human plasma and platelet concentrates. Br J Haematol 2013; 162(4): 442-54.
  53. Darnell ME, Taylor DR. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion 2006; 46(10): 1770-7.
  54. Leclercq I, Batéjat C, Burguière AM, Manuguerra JC. Heat inactivation of the M iddle E ast respiratory syndrome coronavirus. Influenza Other Respir Viruses 2014; 8(5): 585-6.
  55. Hashem AM, Hassan AM, Tolah AM, Alsaadi MA, Abunada Q, Damanhouri GA, et al. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates. Transfus Med 2019; 29(6): 434-41.
  56. Hindawi SI, Hashem AM, Damanhouri GA, El-Kafrawy SA, Tolah AM, Hassan AM, et al. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light. Transfusion 2018; 58(1): 52-9.
  57. Barjas-Castro ML, Angerami RN, Cunha MS, Suzuki A, Nogueira JS, Rocco IM, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016; 56(7): 1684-8.
  58. Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, Müller TH, et al. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively. Transfusion 2018; 58(9): 2202-7.
  59. WHO. Global database on blood safety: report 2004–2005. 2008, World Health Organization.
  60. Bansal N, Raturi M. COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period. Transfus Clin Biol 2021; 28(3): 310-2. 
  61. Routray SS, Ray GK, Prakash S, Sahu A, Naik A, Mukherjee S. Impact of COVID-19 on blood donor deferral patterns during the COVID-19 pandemic: A retrospective analysis. Vox Sang 2022; 117(5): 656-63. 
  62. Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, et al. COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes. Clin Microbiol Rev 2022; 35(3): e0020021.
  63. Casadevall A, Scharff MD. Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother 1994; 38(8): 1695-1702.
  64. Casadevall A, Pirofski LA. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol 2003; 24(9): 474-8.
  65. Roback JD, Guarner J. Convalescent plasma to treat COVID-19: possibilities and challenges. JAMA 2020; 323(16): 1561-2.
  66. Baldeón ME, Maldonado A, Ochoa-Andrade M, Largo C, Pesantez M, Herdoiza M, et al. Effect of convalescent plasma as complementary treatment in patients with moderate COVID-19 infection. Transfus Med 2022; 32(2): 153-61.
  67. Munir MA, Tandiabang PA, Setyawati T, Basry A, Cyio AD, Rahman N. Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review. Transfus Clin Biol 2021; 28(3): 271-5. 
  68. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020; 130(6): 2757-65.
  69. Ko JH, Seok H, Cho SY, Ha YE, Baek JY, Kim SH, et al. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antivir Ther 2018; 23(7): 617-22.
  70. Atyeo C, Fischinger S, Zohar T, Slein MD, Burke J, Loos C, et al. Distinct early serological signatures track with SARS-CoV-2 survival. Immunity 2020; 53(3): 524-32.
  71. Qian Z, Zhang Z, Ma H, Shao S, Kang H, Tong Z. The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials. Front Immunol 2022; 13: 964398.
  72. Jorda A, Kussmann M, Kolenchery N, Siller-Matula JM, Zeitlinger M, Jilma B, et al. Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis. Front Immunol 2022; 13: 817829.
  73. Kober C, Manni S, Wolff S, Barnes T, Mukherjee S, Vogel T, et al. IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools. PLoS One 2022; 17(1): e0262162.
  74. Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020; 370(6515): eabd4585.
  75. Troxel AB, Petkova E, Goldfeld K, Liu M, Tarpey T, Wu Y, et al. Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis. JAMA Netw Open 2022; 5(1): e2147331.
  76. Focosi D, Casadevall A. Convalescent plasma in outpatients with COVID-19. Lancet Respir Med 2022; 10(3): 226-8.
  77. Wang Y, Ma Y, Xu Y, Liu J, Li X, Chen Y, et al. Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma. Emerg Microbes Infect 2022; 11(1): 424-7.
  78. Zhang L, Li Q, Liang Z, Li T, Liu S, Cui Q, et al. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerg Microbes Infect 2022; 11(1): 1-5.
  79. Sheward DJ, Kim C, Ehling RA, Pankow A, Castro Dopico X, Dyrdak R, et al. Neutralisation sensitivity of the SARS-CoV-2 omicron (B. 1.1. 529) variant: a cross-sectional study. Lancet Infect Dis 2022; 22(6): 813-20. 
  80. Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, et al. Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19. JAMA Oncol 2021; 7(8): 1167-75.
  81. Hatzl S, Eisner F, Schilcher G, Kreuzer P, Gornicec M, Eller P, et al. Response to “COVID-19 in persons with haematological cancers”. Leukemia 2020; 34(8): 2265-70.
  82. Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, et al. SARS-CoV-2 viral load predicts mortality in patients with and without cancer who are hospitalized with COVID-19. Cancer Cell 2020; 38(5): 661-671. e2.
  83. Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, et al. Convalescent plasma therapy  for  B-cell–depleted  patients  with protracted COVID-19. Blood 2020; 136(20): 2290-5.
  84. Senefeld JW, Franchini M, Mengoli C, Cruciani M, Zani M, Gorman EK, et al. COVID-19 convalescent plasma for the treatment of immunocompromised patients: A Systematic Review and Meta-analysis. JAMA Netw Open 2023; 6(1): e2250647.
  85. RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med 2021; 9(12): 1419-26.
  86. Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, et al. Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results. N Engl J Med. 2021; 384(6): 497-511. 
  87. Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, et al. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent Sci 2020; 6(5): 672-83.
  88. Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol 2021; 6(5): 563-73.
  89. Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y, et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19： a meta-analysis. Ann Med 2022; 54(1): 516-23.
  90. Lung T, Kazatchkine MD, Risch L, Risch M, Nydegger UE. A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19. Transfus Apher Sci 2020; 59(5): 102936.
  91. Marovich M, Mascola JR, Cohen MS. Monoclonal antibodies for prevention and treatment of COVID-19. JAMA 2020; 324(2): 131-2.
  92. Dodd RY, Xu M, Stramer SL. Change in donor characteristics and antibodies to SARS-CoV-2 in donated blood in the US, June-August 2020. JAMA 2020; 324(16): 1677-9.
  93. Schrottmaier WC, Salzmann M, Badrnya S, Mussbacher M, Kral-Pointner JB, Morava S, et al. Platelets mediate serological memory to neutralize viruses in vitro and in vivo. Blood Adv 2020; 4(16): 3971-6.
  94. Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care 2018; 22(1): 285.
  95. Stahl K, Bode C, David S. First do no harm--beware the risk of therapeutic plasma exchange in severe COVID-19. Crit Care 2020; 24(1): 363.
  96. Enguita-Germán M, Librero J, Leache L, Gutiérrez-Valencia M, Tamayo I, Jericó C, et al. Role of the AB0 blood group in COVID-19 infection and complications:  A  population-based  study.   Transfus Apher Sci 2022; 61(3): 103357.
  97. Zaidi FZ, Zaidi ARZ, Abdullah SM, Zaidi SZA. COVID-19 and the ABO blood group connection. Transfus Apher Sci 2020; 59(5): 102838.
  98. Gutiérrez-Valencia M, Leache L, Librero J, Jericó C, Enguita Germán M, García-Erce JA. ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis. Transfusion 2022; 62(2): 493-505.
  99. Behera B, Rout B, Sahoo D. ABO blood grouping and
    COVID-19: a hospital-based study in Eastern India. Egyptian Journal of Medical Human Genetics 2022; 23(1): 1-6.
  100. Gamboa-Aguilar J, Zamorano-Montaño ÁC, Enríquez-Osorio A, Torres-Cubillas W, López-Arroyo JL, Chapol JAM, et al. Abo Blood Group, Atherothrombotic Comorbidities, and COVID-19: A Case-Control Study of their Association in the Mexican Population. Arch Med Res 2022; 53(1): 100-8.







 







Sci J Iran Blood Transfus Organ 2023;20 (1): 66-80
 
Review Article
 


COVID-19 and Transfusion

Kazemi Babaahmadi N.1, Kheirandish M.1


1Blood  Transfusion  Research  Center,  High  Institute  for  Research  and  Education  in  Transfusion Medicine, Tehran, Iran



Abstract
Background and Objectives
Coronavirus disease 2019 (COVID-19) which is caused by SARS-COV-2 has affected most parts of the world in a short period. Transfusion services are also affected during the emergence of a pandemic of this magnitude. Due to the widespread outbreak of SARS-COV-2, new guidelines have been adopted in blood transfusion centers. Considering the impact of the SARS-COV-2 pandemic on blood transfusion services, blood donation, blood safety, and the use of blood products as a treatment for COVID-19 are addressed in this article.

Materials and Methods
In this review, keywords were searched in Science Direct, PubMed, and Scopus databases, and the sites of Nature Science, Elsevier, Cell, BMJ, Blood, Transfusion, and Lancet journals, and finally 99 articles were used.

Results
In this article, in addition to a brief review of patient blood management, blood safety, and donor safety during the COVID-19 pandemic, the use of blood products as a treatment is considered.

Conclusions 
Hospitals and blood centers have created new policies and guidelines to protect donors and blood supplies including adding new questions to the donor questionnaire and adopting new deferrals for COVID-19 infection and vaccination. Although hyperimmune plasma (convalescent plasma) is proposed as a possible treatment, there are some contradictions in this field.

Key words: COVID-19, Transfusion, Plasma, SARS-COV-2









Received:  10 Jan 2023
Accepted: 17 Jan 2023



Correspondence: Kheirandish M., PhD of Immunology. Associate Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 88602395; Fax: (+9821) 88628741
E-mail: m.kheirandisah@ibto.ir

 
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kazemi Babaahmadi N, Kheirandish M. COVID-19 and Transfusion. Sci J Iran Blood Transfus Organ 2023; 20 (1) :66-80
URL: http://bloodjournal.ir/article-1-1482-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 1 (Spring 2023) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.08 seconds with 39 queries by YEKTAWEB 4660